Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a -33.742% hERG inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a CC(=O)n1cc(C=C2C(=O)NC(=O)NC2=O)c2ccccc21
b N=C1S/C(=C\c2ccco2)C(=O)N1c1ccc2c(c1)OCO2
c CC(C)(CNC(=O)c1cccc(NS(=O)(=O)c2ccc(Br)cc2)c1)N1CCOCC1
d COC(=O)CCSCC(=O)Nc1ccc(S(=O)(=O)N2CCOCC2)cc1OC
e Cc1[nH][nH]c(=O)c1C=NCc1cccc(C(F)(F)F)c1
Answer: c. CC(C)(CNC(=O)c1cccc(NS(=O)(=O)c2ccc(Br)cc2)c1)N1CCOCC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)(CNC(=O)c1cccc(NS(=O)(=O)c2ccc(Br)cc2)c1)N1CCOCC1
CC(C)(CNC(=O)c1cccc(NS(=O)(=O)c2ccc(Br)cc2)c1)N1CCOCC1
3-[(4-bromophenyl)sulfonylamino]-N-(2-methyl-2-morpholin-4-ylpropyl)benzamide